Evidence map›Paper›PMID 38298264›Full record

ArticleFoot & ankle orthopaedics2024

Open Reduction Internal Fixation vs Primary Arthrodesis for Lisfranc Fracture-Dislocations: A Cost Analysis.

Arinze Ochuba, Christopher J Murdock, Amy L Xu, Morgan Snow, Jessica Schmerler, Christopher R Leland, Claire McDaniel, John Thompson, Amiethab A Aiyer

Open access · goldAbstract read
In one paragraph

Article in Foot & ankle orthopaedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Arinze OchubaOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.ORCID https://orcid.org/0000-0003-4740-4531
Christopher J MurdockOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Amy L XuOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-3651-2361
Morgan SnowOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Jessica SchmerlerOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Christopher R LelandMassachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0001-8821-6866
Claire McDanielOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
John ThompsonOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Amiethab A AiyerOrthopaedic Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
Johns Hopkins Hospital · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lisfranc fracture-dislocation is an uncommon but serious injury that currently lacks universal consensus on optimal operative treatment. Two common fixation methods are open reduction and internal fixation (ORIF) and primary arthrodesis (PA). The objective of this study is to analyze the cost difference between ORIF and PA of Lisfranc injuries, along with the contribution of medical services to overall costs. Methods: This was a retrospective cost analysis of the MarketScan database from 2010 to 2020. MarketScan is an insurance and commercial claims database that integrates deidentified patient information. It captures person-specific clinical utilization, expenditures, and enrollment across inpatient and outpatient services. Patients undergoing primary ORIF ( Results: From 2010 to 2020, a total of 7268 patients underwent operative management of Lisfranc injuries, with 5689 (78.3%) ORIF and 1579 (21.7%) PA. PA was independently associated with increased net and total payment and coinsurance, clinic visits, and imaging, and patients attended significantly more PT sessions. Conclusion: Using this large database that does not characterize severity or extent of injury, we found that treatment of Lisfranc fracture-dislocation with ORIF was associated with substantially lower initial episode of treatment costs compared with PA. Specific excessive cost drivers for PA were clinic visits, PT sessions, and imaging. Level of Evidence: Level III, retrospective cohort study.

Indexed as

cost analysisLisfranc fracture-dislocationMarketscanopen reduction internal fixationprimary arthrodesis

Identifiers

PMID38298264
PMCPMC10829492
OpenAlexW4391375699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.